Screener
Travere Therapeutics, Inc. TVTX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.74B.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001438533-26-000042
FAQ
- What is Travere Therapeutics, Inc.'s market capitalization?
- Travere Therapeutics, Inc. (TVTX) reported market capitalization of $2.74B in Q1 2026.
- How has Travere Therapeutics, Inc.'s market capitalization changed year-over-year?
- Travere Therapeutics, Inc.'s market capitalization increased by 72.3% year-over-year, from $1.59B to $2.74B.
- What is the long-term trend for Travere Therapeutics, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s market capitalization has grown at a 17.4% compound annual growth rate (CAGR), from $1.53B to $3.42B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Travere Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude